APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 75 filers reported holding APTINYX INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16 | -65.2% | 224,265 | -40.9% | 0.00% | – |
| Q1 2023 | $46 | +31.4% | 379,326 | +199.2% | 0.00% | – |
| Q4 2022 | $35 | -99.9% | 126,777 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +36.4% | 126,777 | +113.5% | 0.00% | – |
| Q2 2022 | $33,000 | -86.3% | 59,385 | -14.8% | 0.00% | -100.0% |
| Q4 2020 | $241,000 | -68.5% | 69,703 | -69.2% | 0.00% | -66.7% |
| Q3 2020 | $765,000 | -27.1% | 225,979 | -10.2% | 0.00% | -40.0% |
| Q2 2020 | $1,049,000 | +145.7% | 251,588 | +27.3% | 0.01% | +150.0% |
| Q1 2020 | $427,000 | +10.9% | 197,580 | +75.5% | 0.00% | 0.0% |
| Q4 2019 | $385,000 | +2.4% | 112,599 | +4.5% | 0.00% | 0.0% |
| Q3 2019 | $376,000 | +92.8% | 107,761 | +84.7% | 0.00% | +100.0% |
| Q2 2019 | $195,000 | – | 58,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |